Omid Benjamin Mehdizadeh

Omid Mehdizadeh practices at Saint John's Physician Partners in Santa Monica, California.

Omid Mehdizadeh's NPI, 1770816464, was assigned on September 12, 2009. Omid Mehdizadeh graduated from UC Davis School of Medicine in 2012. Omid Mehdizadeh holds California license 150014.

Omid Mehdizadeh's primary practice is Saint John's Physician Partners, at 2125 Arizona Ave, Santa Monica, CA 90404-1337. The practice phone is (310) 582-7450.

Omid Mehdizadeh's primary practice is Saint John's Physician Partners in Santa Monica, California. Omid Mehdizadeh is also affiliated with Providence Saint John's Health Center. The medical group on file is Saint John's Physician Partners. Dmand AI also links Omid Mehdizadeh to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Omid Mehdizadeh practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Omid Mehdizadeh's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Omid Mehdizadeh is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Omid Mehdizadeh is licensed in California.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Omid Mehdizadeh treats.

CMS data shows 1,980 Medicare services from Omid Mehdizadeh across 16 procedure codes in 2024, for 608 Medicare patients. Medicare paid $208,714 for them.

CMS counts 608 Medicare patients who saw Omid Mehdizadeh in 2024. The largest group is 75 to 84, with 256 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Omid Mehdizadeh's median patient age at 70, with 53% women.

In 2024, Omid Mehdizadeh wrote 913 Medicare Part D claims for 344 patients. 97% of them were for generic drugs. CMS names the drug for 769 of them, across 17 drugs with 11 or more claims each, at $11,507 in total drug cost. In 2023, CMS named 616 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Omid Mehdizadeh for performance year 2024, reported as part of a group. Omid Mehdizadeh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Omid Mehdizadeh as offering telehealth. CMS counts 39 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Omid Mehdizadeh, more than 59% of the clinicians it reports for that procedure.

Dmand AI links 15 papers to Omid Mehdizadeh, published from 2008 to 2022. 2019 was the busiest year, with 5. The most frequent topics are Deglutition Disorders, Deglutition and Esophageal Sphincter, Upper. Omid Mehdizadeh has published most often in Laryngoscope. Omid Mehdizadeh's most frequent co-authors are Peter Charles Belafsky, MD, PhD, Shumon Ian Dhar, MD and Yuval Nachalon, MD.

CMS Open Payments shows 76 general payments to Omid Mehdizadeh from 17 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Inspire Medical Systems, Inc. paid the most, $1,228.

Omid Mehdizadeh graduated from UC Davis School of Medicine in 2012.

Omid Mehdizadeh is in network with 16 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.